Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymp

详细信息    查看全文

• 作者：Rishi G. Vaswani ; Victor S. Gehling ; Les A. Dakin ; Andrew S. Cook ; Christopher G. Nasveschuk ; Martin Duplessis ; Priyadarshini Iyer ; Srividya Balasubramanian ; Feng Zhao ; Andrew C. Good ; Robert Campbell ; Christina Lee ; Nico Cantone ; Richard T. Cummings ; Emmanuel Normant ; Steven F. Bellon ; Brian K. Albrecht ; Jean-Christophe Harmange ; Patrick Trojer ; James E. Audia ; Ying Zhang ; Neil Justin ; Shuyang Chen ; Jon R. Wilson ; Steven J. Gamblin
• 刊名：Journal of Medicinal Chemistry
• 出版年：2016
• 出版时间：November 10, 2016
• 年：2016
• 卷：59
• 期：21
• 页码：9928-9941
• 全文大小：731K
• 参考文献：
• ISSN：1520-4804

文摘